News Release

Information
New stock price board in our “Investor Relations” page
Information
GNI’s actual stance towards suspicious trading practices of our stock
Information
GNI’s stance towards suspicious trading practice of our stock
Information
Regarding some speculative information on the transaction between GNI Group and Catalyst Biosciences
Information
Q&A of Cullgen and Astellas’ Collaboration Agreement
Information
Notice of maintenance and upgrade of our website
Information
GNI Group summary Q&A from Q1 2023 financial results analyst call and other recent inquiries
Information
GNI Group FY2023Q1 Earnings Call Transcript
Information
CBIO files 2023Q1 10-Q (quarterly report)
Information
CBIO submits Form 8-K regarding its Nasdaq listing status
Information
GNI Group summary Q&A from FY2022 AGM
Information
CBIO filed 10-K
Information
22nd Annual General Meeting of Shareholders Measures to Prevent the Spread of Covid 19
Information
Impacts of Silicon Valley Bank closure
Information
GNI Group summary Q&A from full-year 2022 financial results analyst call and other recent inquiries